论文部分内容阅读
Objective Hepatocellular carcinoma(HCC)is one of the leading causes of cancerrelated death world-wide,especially in China.Chemotherapy is still the main treatment of HCC since many HCC patients fail to receive surgery resection for poor size and location of tumor,or tumor recurrence and metastasis.